Conformational analysis of an anxiolytic agent: Tandospirone in aqueous solution

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 13, 1997, Pages 1659-1664

  Igarashi, Jun Etsu ^a   Nishimura, Tamiki ^a   Sunagawa, Makoto ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BUFFER; CHLOROFORM; TANDOSPIRONE;

AQUEOUS SOLUTION; ARTICLE; DRUG CONFORMATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; MOLECULAR MODEL; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0030858726     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00289-8     Document Type: Article

References (20)

1. Ishizumi, K.; Kojima, A.; Antoku, F., Chem. Pharm. Bull., 1991, 39, 2288.
2. a) Shimizu, H.; Tatsuno, T.; Hirose, A.; Tanaka, H.; Kumasaka, Y.; Nakamura, M., Life Sci., 1988, 42, 2419.
3. b) Tanaka, H.; Shimizu, H.; Tatsuno, T. Hirose, A.; Kumasaka, Y.; Nakamura, M., Japan. J. Pharmacol., 1990, 52, 504.
4. a) Hamik, A.; Oksenberg, D.; Fischette, C.; Petrouka, S. J., Biol. Psychiatry, 1990, 28, 99.
5. b) Godbout, R.; Chaput, Y.; Blier, P.; Montigny, C. D., Neuropharmacology, 1991, 30, 679.
6. a) Shimizu, H.; Hirose, A.; Tatsuno, T.; Nakamura, M.; Junki, K., Japan. J. Pharmacol., 1987, 45, 493.
7. b) Tatsuno, T.; Shimizu, H.; Hirose, A.; Tanaka, H.; Kumasaka, Y.; Nakamura, M., Pharmacology Biochemistry and Behavior, 1989, 32, 1049.
8. Shimizu, H.; Karai, N.; Hirose, A.; Tatsuno, T.; Tanaka, H.; Kumasaka, Y. Nakamura, M., Japan. J. Pharmacol., 1988, 46, 311.
9. a) Sannerud, C. A.; Ator, N. A.; Griffiths, R. R., Drug and Alcohol Dependence, 1993, 32, 195.
10. b) Kataoka, Y.; Shibata, K.; Miyazaki, A.; Inoue Y.; Tominaga, K.; Koizumi, S.; Ueki, S.; Niwa, M., Neuropharmacology, 1991, 30, 475.
11. a) Raghupathi, R. K.; Rydelek-Fitzgerald, L.; Teitler, M.; Glennon, R. A., J. Med. Chem., 1991, 34, 2633.
12. b) van Steen, B. J.; van Wijngaarden, I.; Tulp, M.; Th. M.; Soudijn, W., J. Med. Chem., 1993, 36, 2751.
13. van Steen, B. J.; van Wijngaarden, I.; Tulp, M. Th. M.; Soudijn, W., J. Med. Chem., 1994, 37, 2761.
14. 1 blocks of 1024 complex points each in the t2 dimension and averaged 16 scans per block during the recycle delay of 3.0 sec. for the NOESY. The data sets were processed using the EDL (JEOL Inc., Tokyo, Japan) on a VAX 3200 workstation.
15. IR spectra were recorded at room temperature on a Perkin Elmer 1600 FT-IR spectrometer using a KBr solution cell with an optical pathlength of 0.1mm. lmg of Samples were dissolved in 10ml of chloroform.
16. Yasuda, N.; Nakamura, A; Tsuboi, M., J. Heterocyclic Chem., 1987, 24, 303
17. Janson, T. R.; Kane, A. R.; Sullivan, J. F.; Knox, K.; Kenney M. E., J. Am. Chem. Soc., 1969, 91, 5210.
18. Norman, M. H.; Minick, D. J.; Rigdon, G. C.; J. Med. Chem., 1996, 39, 149.
19. a) Macromodel ver. 4.5: Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Canfield, C.; Chang, G. Hendrickson, T.; Still, W. C., J. Comput Chem., 1990, 11, 440. AMBER* force field was used with all-atom of the molecule and Gasteiger charges. Conformations within 10 kJ of the lowest energy were examined.
20. Jorgensen, W. L., Acc. Chem. Res., 1989, 22, 184.